Linaclotide
- CAS No.
- 851199-59-2
- Chemical Name:
- Linaclotide
- Synonyms
- Linacllotide;Argpessin;inaclotide;Linalotide;Rinalodipine Acetate;CY-14;Liclotide;Linaclotide;Linaelotide;Linaelotide Acetate
- CBNumber:
- CB82498818
- Molecular Formula:
- C59H79N15O21S6
- Molecular Weight:
- 1526.75
- MDL Number:
- MFCD20526656
- MOL File:
- 851199-59-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Linaclotide ≥95% (HPLC) | SML3710 | 5 mg | $143 |
| Linaclotide ≥95% (HPLC) | SML3710 | 25 mg | $572 |
| Linaclotide ≥95% | 24085 | 500μg | $36 |
| Linaclotide ≥95% | 24085 | 1mg | $63 |
| Linaclotide ≥95% | 24085 | 5mg | $203 |
| More product size | |||
| Melting point | 231-235°C (dec.) |
|---|---|
| Boiling point | 2045.0±65.0 °C(Predicted) |
| Density | 1.60 |
| storage temp. | Hygroscopic, Refrigerator, under inert atmosphere |
| solubility | DMSO (Slightly, Heated), Methanol ((Slightly, Heated)), Water (Slightly, Heated) |
| pka | 3.05±0.10(Predicted) |
| form | Solid |
| color | White |
| Stability | Hygroscopic |
| InChIKey | KXGCNMMJRFDFNR-VRMHCMCOSA-N |
| FDA UNII | N0TXR0XR5X |
| ATC code | A06AX04 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302 | |||||||||
| Precautionary statements | P264-P270-P301+P312-P330-P501 | |||||||||
| WGK Germany | WGK 3 | |||||||||
| Storage Class | 11 - Combustible Solids | |||||||||
| Hazard Classifications | Acute Tox. 4 Oral | |||||||||
| Hazardous Substances Data | 851199-59-2(Hazardous Substances Data) | |||||||||
| NFPA 704 |
|
Linaclotide price More Price(63)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | SML3710 | Linaclotide ≥95% (HPLC) | 851199-59-2 | 5 mg | $143 | 2026-04-30 | Buy |
| Sigma-Aldrich | SML3710 | Linaclotide ≥95% (HPLC) | 851199-59-2 | 25 mg | $572 | 2026-04-30 | Buy |
| Cayman Chemical | 24085 | Linaclotide ≥95% | 851199-59-2 | 500μg | $36 | 2026-04-30 | Buy |
| Cayman Chemical | 24085 | Linaclotide ≥95% | 851199-59-2 | 1mg | $63 | 2026-04-30 | Buy |
| Cayman Chemical | 24085 | Linaclotide ≥95% | 851199-59-2 | 5mg | $203 | 2026-04-30 | Buy |
Linaclotide Chemical Properties,Uses,Production
Description
In August 2012, the US FDA approved linaclotide (also referred to as MD-1100), a first-in-class, orally administered 14-amino acid peptide as a therapy for patients suffering from chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Linaclotide and its active metabolite MM-419447, which results from the cleavage of the C-terminal tyrosine residue by carboxypeptidase A, mimic the actions of the endogenous intestinal peptides guanylin (15 amino acids) and uroguanylin (16 amino acids) by activating guanylyl cyclase C (GC-C) on the intestinal epithelium. Activation of GC-C leads to increased intra- and extracellular levels of cGMP and activation of the CFTR ion channel, resulting in increased levels of HCO3-, Cl-, and water in the intestinal lumen and accelerated gastrointestinal transit. Based on an in vitro assaymeasuring the accumulation of cGMP in T84 cell exposed to an agonist, the EC50 of linaclotide at pH 7.0 was 99±17.5 nM. In preclinical studies in mice using the transit of activated charcoal as ameasure of efficacy, linaclotide at 100 μg/kg significantly accelerated transit compared to wild-type mice treated with charcoal only or GC-Cnullmice treatedwith and without linaclotide.118 Efficacy was also seen in rats treatedwith linaclotide atdoses of 5, 10, and 20 μg/kg. Linaclotide has been synthesized using conventional solid-phase peptide technology.
Originator
Ironwood Pharmaceuticals and Forest Pharmaceuticals (United States)
Uses
Linaclotide is a guanylate cyclase-C agonist currently being studied in Phase 3 trials for the treatment of irritable bowel syndrome with constipation.
Definition
ChEBI: Linaclotide is a fourteen-membered heterodetic cyclic peptide consisting of Cys, Cys, Glu, Tyr, Cys, Cys, Asn, Pro, Ala, Cys, Thr, Gly, Cys and Tyr residues joined in sequence and cyclised by three disulfide bonds: between Cys(1) and Cys(6), between Cys(2) and Cys(10), and between Cys(5) and Cys(13). Used for treatment of irritable bowel syndrome accompanied by constipation. It has a role as a guanylate cyclase 2C agonist.
brand name
Linzess
Biological Functions
Linaclotide works by increasing fluid in your intestines and helping speed up movement of food through the gut. Linaclotide may improve stool texture and lessen symptoms such as bloating, abdominal pain/discomfort, straining, and feelings of incomplete bowel movements.
Side effects
Side effects include:Diarrhea, abdominal pain, flatulence, abdominal distension, viral gastroenteritis, headache, upper respiratory tract infection, sinusitis
Linaclotide Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Chengdu Shengnuo Biopharm Co.,Ltd | +86-13880038419 | info@snbiopharm.com | China | 68 | 58 |
| AFINE CHEMICALS LIMITED | +86-571-85134551 +86-18958018566 | info@afinechem.com | China | 15079 | 58 |
| Apextide Co Ltd | +86-15300650552; +86-15300650552 | info@apextide.com | China | 91 | 58 |
| Hainan Fubai Trading Co., LTD | +852-70284493 +852-70284493 | 13313004729@163.com | China | 103 | 58 |
| RongNa Biotechnology Co.,Ltd | +86-86-13583358881 +8618560316533 | Brad@rongnabiotech.com | China | 3372 | 58 |
| Hydebio Labs Co.,Limited | +86-18100690299 +86-18100690299 | mrkt@hydebiolabs.com | China | 126 | 58 |
| Shandong Hanjiang Chemical Co., Ltd | +86-0533-2066820 +8618369939125 | hanson@sdhanjiang.com | China | 1000 | 58 |
| BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | +86-18600796368 | sales@sjar-tech.com | China | 538 | 58 |
| Hebei Yanxi Chemical Co., Ltd. | +86-17531190177 | faithe@yan-xi.com | China | 5853 | 58 |
| Shanghai Affida new material science and technology center | +86-15081010295 | admin@oudaxin.com | China | 114 | 58 |
Related articles
- Linaclotide: Pharmacology, Pharmacokinetics and Clinical Applications
- Linaclotide, a minimally absorbed peptide, enhances fluid secretion and gastrointestinal transit by activating GC-C receptors,....
- Sep 29，2024
- Mechanism and Side effects of Linaclotide
- Linaclotide, (sold under the brand name Linzess in the US and Mexico, and as Constella elsewhere)is a drug used to treat irrit....
- May 6，2022
View Lastest Price from Linaclotide manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-07-31 | Linaclotide
851199-59-2
|
0.99 | RongNa Biotechnology Co.,Ltd | ||||
 |
2026-07-31 | Linaclotide
851199-59-2
|
1g | More Than 99% | 100kg/Month | BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | ||
 |
2026-07-31 | Linaclotide
851199-59-2
|
$400.00-1000.00 | 1g | 99% | 5000 | HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD |
-
- Linaclotide
851199-59-2
- 0.99
- RongNa Biotechnology Co.,Ltd
-
- Linaclotide
851199-59-2
- $0.00
- More Than 99%
- BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
-
- Linaclotide
851199-59-2
- $400.00-1000.00
- 99%
- HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
